American International Group’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-2,726
Closed -$29K 4948
2016
Q1
$29K Hold
2,726
﹤0.01% 4153
2015
Q4
$80K Buy
2,726
+171
+7% +$5.17K ﹤0.01% 3653
2015
Q3
$81K Buy
2,555
+3
+0.1% +$144 ﹤0.01% 3643
2015
Q2
$151K Buy
2,552
+460
+22% +$32.4K ﹤0.01% 3277
2015
Q1
$224K Hold
2,092
﹤0.01% 2857
2014
Q4
$196K Sell
2,092
-82
-4% -$7.82K ﹤0.01% 2956
2014
Q3
$167K Sell
2,174
-2
-0.1% -$157 ﹤0.01% 3122
2014
Q2
$195K Buy
2,176
+985
+83% +$60.4K ﹤0.01% 2997
2014
Q1
$63.7K Buy
1,191
+28
+2% +$924 ﹤0.01% 3739
2013
Q4
$29.3K Sell
1,163
-11
-0.9% -$262 ﹤0.01% 3980
2013
Q3
$32.1K Buy
1,174
+479
+69% +$15.4K ﹤0.01% 3911
2013
Q2
$25.1K Buy
+695
New +$26.1K ﹤0.01% 3850

Other funds holding PTX

American International Group's PTX Position: Q2 2016 in Review

American International Group sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2016, closing a stake of 2,726 shares — an estimated $29K sold.

American International Group first reported a position in PTX in Q2 2013 and held it in 12 quarters. The position peaked at $224K in Q1 2015. 56 funds tracked by Wall St. Rank hold PTX as of Q2 2016.

  • American International Group reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2016 after selling out during the quarter.
  • American International Group sold 2,726 Pernix Therapeutics Holdings, Inc. shares in Q2 2016, an estimated $29K.
  • American International Group first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2013 and held it in 12 quarters.
  • American International Group's Pernix Therapeutics Holdings, Inc. position peaked at $224K in Q1 2015.
  • 56 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2016.

Based on American International Group's 13F filing for Q2 2016, filed 11 Aug 2016.